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Some Autism Spectrum Disorders (ASD) likely arise as a result of abnormalities during early 31 
embryonic development of the brain. Studying human embryonic brain development directly is 32 
challenging, mainly due to ethical and practical constraints. However, the recent development of 33 
cerebral organoids provides a powerful tool for studying both normal human embryonic brain 34 
development and, potentially, the origins of neurodevelopmental disorders including ASD. 35 
 2 
Substantial evidence now indicates that cerebral organoids can mimic normal embryonic brain 36 
development and neural cells found in organoids closely resemble their in vivo counterparts. 37 
However, with prolonged culture, significant differences begin to arise. We suggest that cerebral 38 
organoids, in their current form, are most suitable to model earlier neurodevelopmental events 39 
and processes such as neurogenesis and cortical lamination. Processes implicated in ASDs which 40 
occur at later stages of development, such as synaptogenesis and neural circuit formation, may 41 
also be modelled using organoids. The accuracy of such models will benefit from continuous 42 
improvements to protocols for organoid differentiation. 43 
 44 
1. Introduction 45 
Autism spectrum disorders (ASDs) are a group of neurodevelopmental disorders that affect as 46 
many as 1 in 59 children (CDC, 2012). They are characterized by impairments in social 47 
interaction and communication and repetitive and restricted patterns of behaviour, interests or 48 
activities. While these symptoms can be found in any individual across the spectrum, the severity 49 
of the symptoms presented varies, ranging from very mild to very severe. Individuals with ASD 50 
may also present distinct combinations of comorbid features and diagnoses that are not part of 51 
the disorder they were diagnosed with, such as gastrointestinal symptoms, epilepsy, sleep 52 
disruptions, or motor disturbances. This clinical heterogeneity makes it difficult to find a 53 
unifying biological hypothesis to address all the features of ASD and the underlying genetic 54 
causes of ASDs are still under debate. 55 
Studies of large family cohorts have identified at least 65 ASD risk genes with high confidence 56 
(Fischbach and Lord, 2010; Zhao et al., 2007) and hundreds more candidate genes. However, 57 
this only accounts for about 30% of ASD cases, the remainder having nonsyndromic idiopathic 58 
ASD in which the cause is unknown (Fernandez and Scherer, 2017). It is estimated that as many 59 
as 300 – 1000 genes could be targets for rare mutations which greatly increase the risk of ASD, 60 
potentially explaining some idiopathic cases (He et al., 2013; Ronemus et al., 2014). This 61 
extreme genetic heterogeneity makes it very difficult to map the relationship between genotype 62 
and phenotype in ASD (De Rubeis and Buxbaum, 2015). However recent work using network 63 
approaches suggests that autism risk genes converge on a small number of biological pathways 64 
and processes (de la Torre-Ubieta et al., 2016; Gilman et al., 2011; Mullins et al., 2016; Wen et 65 
al., 2016). Gene set enrichment analyses have shown that genes associated with ASD converge 66 
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on pathways and processes that contribute to embryonic brain development, including chromatin 67 
remodelling, neurogenesis and cortical lamination; neuronal physiological maintenance; and 68 
synaptic processes. The convergence of many ASD-risk genes on common molecular pathways 69 
may help explain how a genetically heterogeneous population of individuals exhibit similar 70 
symptoms.  71 
One such point of convergence is synaptogenesis and synapse physiology (Bhandari et al., 2020; 72 
de la Torre-Ubieta et al., 2016; Guang et al., 2018). One of the earliest ASD-risk genes 73 
identified, SHANK3, and many other ASD-risk genes identified subsequently are directly 74 
involved in synapse physiology, highlighting the clear role that dysregulation of synaptogenesis 75 
and synaptic transmission play in ASD pathophysiology. So, ASD has often been viewed as a 76 
disorder of synaptic dysfunction (Zoghbi and Bear, 2012). However, many neurodevelopmental 77 
processes which occur during embryonic and fetal stages, such as neurogenesis and cortical 78 
lamination, are also a point of convergence for ASD risk genes, indicating that ASD can arise 79 
from an earlier point in development (Casanova, 2014; Packer, 2016; Vaccarino et al., 2009). 80 
This view is supported by a recent genome wide association study (GWAS) which showed that a 81 
large proportion of ASD risk genes analysed were expressed most highly during fetal 82 
corticogenesis (Grove et al., 2019). These early stages of brain development are highly dynamic. 83 
One could hypothesize that small changes during these processes could lead to larger effects 84 
later. Key stages of brain development at which ASD-related genes may act are described in 85 
Box1. 86 
Studying human prenatal brain development directly remains a major challenge, due to scarcity 87 
of material and ethical constraints on research using human embryos. Much of our present 88 
understanding of brain development is therefore based on studies using model organisms, 89 
primarily the mouse. However, there are important differences between mouse and human brain 90 
development (Florio and Huttner, 2014). The recent advent of cerebral organoids offers the 91 
potential to study human brain development directly. Cerebral organoids are 3D cultured cell 92 
aggregates derived from pluripotent stem cells (PSCs) which closely resemble embryonic brain 93 
tissue. They contain many of the cell types found in embryonic brains, locally organized in a 94 
similar way to that found in vivo, and exhibit similar behaviours (Lancaster et al., 2013), but the 95 
spatial organisation along major axes (anteroposterior, dorsoventral and mediolateral) found in 96 
embryos is absent in organoids. Organoids have the potential to be invaluable tools for studying 97 
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both normal development and the developmental origins of neurodevelopmental disorders 98 
including ASDs. A number of studies have already used organoids to model neurodevelopmental 99 
disorders as summarised in Table 1.  100 
Protocols for generating human cerebral organoids fall into two main categories. In the first, 101 
PSCs are aggregated and allowed to differentiate in the absence of any specific added 102 
differentiation cues. Such protocols, exemplified by Lancaster et al., 2013, produce heterogenous 103 
organoids containing areas corresponding to various regions of the brain, such as dorsal and 104 
ventral forebrain, hindbrain, hippocampus or choroid plexus. Alternatively, many protocols 105 
include the addition of specific cues that promote formation of a specific region of the brain, 106 
such as dorsal forebrain, ventral forebrain, midbrain, hypothalamus or thalamus (Birey et al., 107 
2017; Qian et al., 2016; Xiang et al., 2019). Such regionalized organoids can be used to 108 
investigate developmental pattering and the effects of mutations on individual brain regions. A 109 
recent study summarized all widely used organoid protocols and compared the transcriptomic 110 
profiles of the organoids grown using a range of published protocols. They found that while each 111 
protocol produced organoids with similar cellular composition, the differentiation trajectories 112 
differed between protocols (Tanaka et al., 2020). Before using cerebral organoids to investigate 113 
normal development or disease states, it is important to understand how accurately they can 114 
recapitulate the in vivo system and what their limitations are. Comparing the transcriptomes of 115 
cortical organoids with those of human fetal cortex shows encouraging similarities. At a global 116 
level, the transcriptome of dorsal forebrain organoids grown for 40-100 days correlated best with 117 
fetal cortex tissue at ages 8-16 p.c.w, indicating that organoids develop at a similar rate to the 118 
fetus (Amiri et al., 2018; Luo et al., 2016; Mariani et al., 2015). The epigenome of organoids is 119 
also similar to that of fetal tissue - analysis of histone modifications showed cortical organoids 120 
were more like fetal brain tissue than adult brain tissue or pluripotent stem cells (Amiri et al., 121 
2018). 122 
Single cell analysis of telencephalic organoids and fetal human cortex showed that they contain 123 
very similar cell types. While excitatory neurons are the most numerous cell type within the 124 
cortex, several other vital cell types are also present. Fetal cortex at ages 15-23 p.c.w contains, in 125 
decreasing order of proportion: excitatory neurons, inhibitory neurons that migrated from the 126 
ventral telencephalon, radial glial, astrocytes, microglial, with a small subset of glia, endothelial 127 
cells, oligodendrocyte progenitor cells and Cajal-Retzius cells (Amiri et al., 2018; Fan et al., 128 
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2018; Zhong et al., 2018). At early stages (1-3 months in culture), human dorsal forebrain 129 
organoids contain mostly excitatory neurons, radial glial and intermediate progenitor cells (Amiri 130 
et al., 2018; Birey et al., 2017; Velasco et al., 2019; Yoon et al., 2019), while at six months there 131 
is an increase in astroglia and inhibitory interneurons (possibly of the olfactory bulbs) begin to 132 
appear (Velasco et al., 2019). Ventral patterned cortical organoids on the other hand, contain 133 
GABAergic neurons, ventral progenitors and astroglial cells, the key cell types found in the 134 
cognate brain structures in vivo. Although organoids show similar cell type composition to that 135 
found in vivo, a recent large scRNA-seq analysis of organoids and primary tissues, showed 136 
organoids lacked cell type and sub-type fidelity indicated by co-expression of different cell-type 137 
markers in organoids when compared to fetal brain (Bhaduri et al., 2020). 138 
Organoid transcriptomes change during differentiation in accordance with the development of 139 
the fetal cortex. Modules of genes co-expressed during cortex development in vivo are conserved 140 
in organoids. These include upregulated genes associated with synaptic transmission, cell 141 
adhesion and neuron differentiation and downregulated cell cycle genes (Amiri et al., 2018; Luo 142 
et al., 2016). Notably, several gene modules co-expressed during organoid development are 143 
enriched with SFARI genes, a curated list of genes associated with ASD, and a quarter of SFARI 144 
genes are differentially expressed during organoid differentiation (Amiri et al., 2018). In vivo, 145 
genes linked to ASD and intellectual disability, including genes associated with chromatin 146 
remodeling, Wnt and Notch signalling, were most highly expressed at 8-16 p.c.w. (Hormozdiari 147 
et al., 2015). Another single-cell transcriptome analysis found around 84% of genes mutated in 148 
disorders affecting neurogenesis showed the same developmental expression trajectory in 149 
organoid and fetal cells (Camp et al., 2015). These studies suggest that organoids can 150 
recapitulate the timeline of events during normal human development during which ASD 151 
causative effects could be taking place. 152 
 153 
2. Possible developmental origins of ASD 154 
2.1 Abnormal neurogenesis and growth of the cerebral cortex 155 
One obvious difference between mouse and human brains is the disproportionately increased size 156 
of the human cerebral cortex. The mechanisms that led to the dramatic expansion of the human 157 
cortex are outlined in Box 2. Enlarged head size is a common feature of ASDs. Some 14%–34% 158 
of autistic patients show macrocephaly (Sacco et al., 2015), due to increased surface area rather 159 
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than increased cortical thickness (Ohta et al., 2016). Increased brain volume has been linked to 160 
the emergence and severity of autistic social deficits (Hazlett et al., 2017). Analysis of head 161 
circumference of children with ASD over the first year of life showed an accelerated increase in 162 
head size (Courchesne et al., 2003). Aberrant brain growth could be due to changes to the balance 163 
between proliferation and differentiation of neural progenitor cells in the embryo (Courchesne et 164 
al., 2011; Florio and Huttner, 2014). Cell-cycle genes have been implicated in ASD based on 165 
differential expression in postmortem ASD brains (Chow et al., 2012). A systems biology 166 
approach analyzing total brain volume and gene expression levels (in blood, given the 167 
unavailability of brain tissue) in ASD toddlers also implicated cell-cycle genes in regulation of 168 
brain size (Pramparo et al., 2015). Mutations in cell cycle control genes have been found in ASD 169 
patients. For example, mutations in the transcriptional regulator ANKRD11 (Ankyrin repeat 170 
domain 11) contribute to ASD (Iossifov et al., 2014; Marshall et al., 2008). ANKRD11 regulates 171 
neural progenitor proliferation through interaction with histone deacetylases (Zhang et al., 2004). 172 
Mutations in PTEN (phosphatase and tensin homologue on chromosome ten), a phosphatase that 173 
acts to inhibit the AKT/mTOR pathway, are associated with macrocephaly (Butler et al., 2005) 174 
and ASD (Conti et al., 2012; De Rubeis et al., 2014). Pten heterozygous mutant mice have an 175 
increased number of neural progenitors and a decreased total cell number in the mature cerebral 176 
cortex, due to fewer neural progenitors exiting the cell cycle (Chen et al., 2015). In contrast, 177 
PTEN homozygous mutants in human cerebral organoids exhibited an expanded VZ and oSVZ, 178 
delayed neuronal differentiation and surface expansion and folding (Li et al., 2017). 179 
Numerous mouse studies demonstrate that mutations in cell cycle genes can cause overgrowth of 180 
cerebral cortex. For example, knockdown of Ankrd11 by in utero electroporation at E13/14 181 
revealed decreased neural progenitors and underproduction of neurons, an effect that was 182 
rescued by administering a histone acetyltransferase inhibitor (Gallagher et al., 2015). 183 
Overexpression of Cdk4/Cyclin D1 via in utero electroporation of mouse brains inhibited the 184 
switch from proliferation to differentiation, resulting in a cortex with a larger surface area, 185 
reminiscent of the increased surface area found in human ASD patients (Lange et al., 2009; Pilaz 186 
et al., 2016) 187 
2.1.1 Progenitor proliferation and neurogenesis in human cerebral organoids 188 
Human cerebral organoids faithfully recapitulate embryonic cortical structures – they generate 189 
neuroepithelium and PAX6+ SOX2+ progenitors are found at its apical surface, closely 190 
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resembling the embryonic ventricular zone. An adjacent layer of TBR2+ intermediate progenitor 191 
cells indicates the presence of an SVZ, and expression of neuronal markers TBR1 and MAP2 at 192 
the basal surface indicate cortical plate (Lancaster et al., 2013). The presence of an outer SVZ 193 
(oSVZ) as indicated by expression of outer RG markers HOPX and PTPRZ1 has also been 194 
reported in some cerebral organoids (Qian et al., 2016; Qian et al, 2020). This is important, as 195 
oSVZ progenitors are thought to drive cortical expansion in human and are absent in mice. Thus, 196 
human organoids are likely to be an invaluable tool to study this population of cells.  197 
Human cortical organoids have been used to study disorders with a brain size abnormality. 198 
Organoids grown from iPSCs derived from a patient with severe microcephaly had reduced 199 
neural tissue, resembling the patient phenotype. Analysis of the early stages of organoid 200 
differentiation showed they had smaller neuroepithelia, fewer radial glial cells and more neurons 201 
indicating an imbalance of the symmetric and asymmetric divisions of neural progenitor cells 202 
(Lancaster et al., 2013).  203 
In a study of idiopathic ASD, iPSCs were derived from family members with an ASD and 204 
unaffected close relatives, then cerebral organoids were grown from each. The transcription 205 
factor FOXG1 was found to be significantly overexpressed in the ASD patient-derived 206 
organoids, driving an accelerated cell cycle (Mariani et al., 2015). Transcriptome analysis 207 
showed increased expression of genes associated with neural differentiation and synaptic 208 
transmission in ASD-organoids (Mariani et al., 2015), both of which have been linked to ASD 209 
(De Rubeis et al., 2014; Gilman et al., 2011; Pinto et al., 2014). ASD-organoids showed 210 
increased neural maturation and surplus GABAergic neurons but no effect on excitatory neuron 211 
number, indicating an imbalance of excitatory/inhibitory neurons, a phenotype believed to 212 
underlie some cases of autism. Inhibition of FOXG1 expression restored GABAergic neuronal 213 
numbers to normal (Mariani et al., 2015). 214 
CHD8, one of the most commonly mutated genes in ASD, can negatively regulate WNT 215 
signalling, an essential signalling pathway in brain development. Transcriptome analysis of 216 
forebrain organoids derived from CHD8+/- iPSC lines and their isogenic controls showed 217 
dysregulation of genes associated with neurogenesis, WNT signalling and ECM components 218 
(Wang et al., 2017). Notably, there was significant overlap of these differentially expressed 219 
genes when compared to those found in NPCs and neurons derived from CHD8+/- iPSCs 220 
compared to controls in 2D culture experiments (Wang et al., 2015). Similarly, 23% of 221 
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differentially expressed genes found in CHD8+/- organoids were also found in idiopathic ASD 222 
organoids, with these overlapping genes being enriched with neurogenesis associated genes 223 
(Mariani et al., 2015; Wang et al., 2017). 224 
2.2 Defective neuronal migration / cortical lamination 225 
Disruption to cortical lamination may be a common feature of brain development in ASD 226 
(Casanova, 2014; Stoner et al., 2014). Cortical layers form progressively during embryonic 227 
development, with deep layer neurons being born first and later-born neurons migrating past 228 
them to form the characteristic six-layered laminar architecture of the cortex. Defects in 229 
migration could be indirect effects of altered cell cycle dynamics or proliferation as migration 230 
defects are also observed in the mouse models of the genes discussed above. For example, in 231 
Ankrd11 mutant mice more cells are retained in the VZ and SVZ, resulting in fewer cells in the 232 
cortical plate. Furthermore, there were fewer Satb2-expressing superficial layer neurons and 233 
Tbr1+ deep-layer neurons were positioned inappropriately (Sirmaci et al., 2011). Pten 234 
heterozygous mutant mice showed an increase in superficial layer Cux1-expressing neurons 235 
(Chen et al., 2015).  236 
The transcription factor TBR1 is required for normal cortical lamination and has been implicated 237 
in ASD (Bedogni et al., 2010; De Rubeis et al., 2014; Hevner et al., 2001). Tbr1 is expressed in 238 
deep layer neurons (layer 5/6) and in Tbr1-/- mutant mice, neurons in layer 5 and layer 6 of the 239 
cortical plate are mixed and there is no clear distinction between them (Bedogni et al., 2010; 240 
Hevner et al., 2001). Tbr1 is required to maintain layer 6 identity in the postnatal cortex - 241 
specific deletion of Tbr1 in layer 6 led to increased expression of regulators of layer 5 identity 242 
such as Fezf2 and Bcl11b and a decrease in layer 6 markers/regulators Foxp2 and Tle4 (Fazel 243 
Darbandi et al., 2018).  244 
Before initiating radial migration, newborn cortical neurons undergo a multipolar to bipolar 245 
morphology change. This transition is disrupted in mice deficient for a number of genes 246 
implicated in ASD including Foxg1 (Miyoshi and Fishell, 2012) and Fmr1 (La Fata et al., 2014). 247 
Foxg1, a transcription factor, is expressed in neural progenitors and has multiple roles in 248 
forebrain development in mice (Manuel et al., 2011; Shen et al., 2019). Downregulation of 249 
Foxg1 expression is required to allow cells to progress from multipolar to bipolar morphology 250 
before migrating into the cortical plate (Miyoshi and Fishell, 2012). Delay in multipolar to 251 
bipolar transition impairs the coordinated integration of excitatory neurons with inhibitory 252 
 9 
interneurons, ultimately affecting the ratio of excitatory to inhibitory neurons in the developing 253 
cortex (Mariani et al., 2015; Miyoshi and Fishell, 2012). 254 
 255 
2.2.1 Neuronal migration and cortical lamination in cerebral organoids 256 
Forebrain organoids contain radially aligned RGC processes as seen in vivo (Qian et al., 2018). 257 
Live imaging of neurons migrating from organoids onto a Matrigel surface showed similar 258 
migration rates to ferret cortical explants (Bershteyn et al., 2017). Using this model, migration 259 
defects were observed in organoids derived from iPSCs from Miller-Dieker Syndrome (MDS) 260 
patients; a severe cortical malformation disorder caused by defective cortical neuronal migration. 261 
Imaging analysis showed fewer neurons migrating out of the organoid, reduced migration speed 262 
and track straightness (Bershteyn et al., 2017).  263 
Migratory defects can also be examined by using an ‘assembloid’ approach. By co-culturing 264 
ventral telencephalic organoids with dorsal cortical organoids, interneurons from the ventral 265 
organoids were shown to migrate towards the dorsal forebrain as observed in vivo (Birey et al., 266 
2017). Using this model, assembloids were generated using hiPSCs derived from patients with 267 
Timothy Syndrome (TS), a neurodevelopmental disorder characterized by ASD and epilepsy 268 
(Birey et al.,2017). These assembloids exhibited migration defects in interneurons and increased 269 
residual calcium following depolarization in TS neurons. Timothy syndrome is caused by a gain-270 
of-function mutation in an L-type calcium channel (LTCC) subunit and incubating organoids 271 
with an LTCC blocker successfully reversed the migratory defects (Birey et al., 2017).  272 
Human cortical organoids show some lamination (Figure 1), with progenitor cells located 273 
towards the central lumen and differentiated neurons located towards the outside. Expression of 274 
TBR1, CTIP2 and SATB2 showing similar lamination in day 84 organoids as found in neocortex 275 
at 23 GWs (Qian et al., 2016; Saito et al., 2011). A recent study showed that cutting organoids 276 
into thick organotypic slices, thereby improving nutrient access from the culture medium, greatly 277 
enhanced lamination as indicated by larger and more distinct oSVZ and CP layers. Using this 278 
method, they identified lamination defects in organoids with a DISC1 mutation,  which has been 279 
associated with schizophrenia and autism (Kamiya et al., 2005; Qian et al., 2020). 280 
 281 
2.3 Abnormal synaptogenesis in ASD 282 
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Following neurogenesis, neuronal migration and cortical lamination, neurons next make 283 
connections with their appropriate synaptic partners, thus beginning the formation of neural 284 
circuits. This is known to be important in the pathophysiology of ASD as synaptogenesis is 285 
another point of convergence for ASD-risk genes (Courchesne et al., 2020; de la Torre-Ubieta et 286 
al., 2016). Here, we discuss some of the well-known ASD-risk genes involved in synaptogenesis, 287 
but this is by no means an exhaustive list. A more comprehensive list is provided in a recent 288 
review by Guang and colleagues (Guang et al., 2018).  289 
Some of the first genes implicated in ASD, such as the multiple Ankyrin repeat domain 3 gene 290 
SHANK3, are directly involved in synapse formation and function. SHANK3 was found to be 291 
disrupted in a child affected with Phelan-McDermid syndrome (PMS) in which patients show 292 
poor eye contact, global developmental delay, decreased socialization and stereotypic 293 
movements (Bonaglia et al., 2001). Analysis of more than 60 additional patients showed that 294 
heterozygous loss of SHANK3 is responsible for the neurological phenotypes (Anderlid et al., 295 
2002; Dhar et al., 2010). Subsequently, SHANK3 mutations have been found in numerous ASD 296 
patients (Durand et al., 2007; Gauthier et al., 2010; Moessner et al., 2007). The SHANK protein 297 
family comprises of SHANK1, 2 and 3, scaffold proteins which localize to synapses and interact 298 
with components of the postsynaptic density including guanylate kinase-associated protein 299 
(PSD95), Homer, cortactin-binding protein, and the somatostatin receptor and act to stabilize the 300 
PSD-95/Shank/Homer complexes at the postsynaptic density (Lim et al., 1999). 301 
In mice, Shank1 is required for correct synapse maturation and function. Deleting Shank1 leads 302 
to smaller dendritic spines, thin postsynaptic densities and ultimately weakened synaptic 303 
transmission. Mutant mice showed impaired contextual fear memory, poor long-term retention of 304 
a spatial task and anxiety-like behaviour (Hung et al., 2008). Shank1’s role in synapse 305 
maturation and function was corroborated in in vitro studies where Shank1 was overexpressed in 306 
hippocampal neurons, leading to increased maturation and size of dendritic spines (Sala et al., 307 
2001). Mice heterozygous for Shank3 showed reduced basal synaptic transmission in 308 
hippocampal CA1 neurons and decreased long-term potentiation, an important mechanism in 309 
retaining nascent synapses (Bozdagi et al., 2010). Deleting Shank3B caused reduction in 310 
postsynaptic proteins such as Homer and PSD93. The thickness and length of the postsynaptic 311 
densities were also reduced in addition to lowered spine density. This was accompanied by a 312 
reduction in excitatory synaptic transmission in the striatum. The mice displayed anxiety-like 313 
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behaviours and decreased social interactions similar to human PMS patients (Peca et al., 2011). 314 
In vitro studies knocking down Shank3 in hippocampal neurons led to a lower number but 315 
increased length of dendritic spines supporting evidence from the mouse model that Shank3 is 316 
crucial for dendritic spine function (Roussignol et al., 2005). Furthermore, expressing Shank3 in 317 
aspiny cerebellar granule neurons was found to be sufficient to induce functional dendritic spines 318 
(Roussignol et al., 2005). Recent studies using human iPSCs with SHANK3 knockdown also 319 
found defects in excitatory and inhibitory synaptic transmission (Huang et al., 2019). 320 
Fragile X syndrome (FXS) is an ASD caused by insufficient expression of the FMR1 gene. 321 
Symptoms include intellectual disability, motor abnormalities, anxiety, speech delay, gaze 322 
avoidance and stereotyped repetitive behaviours (Hagerman et al., 1984). Postmortem 323 
neuropathological studies on FXS patients revealed structural defects of dendritic spines 324 
(Comery et al., 1997; Irwin et al., 2000). FMR1 encodes FMRP, a multi-functional mRNA 325 
binding protein involved in the transport and localization of a subset of dendritic mRNAs (Bagni 326 
and Greenough, 2005; Laggerbauer et al., 2001; Li et al., 2001). FMRP is enriched in neurons 327 
and especially at the dendrites, where it represses the translation of many mRNAs that play 328 
important roles in synapse formation and synaptic plasticity (Brown et al., 2001; Darnell et al., 329 
2001; Feng et al., 1997; Miyashiro et al., 2003; Weiler et al., 1997). FMRP represses the 330 
translation of many mRNAs (O'Donnell and Warren, 2002) leading to an increase in rate of basal 331 
protein synthesis in the hippocampus of Fmr1 null mutant mice (Osterweil et al., 2010; Qin et al., 332 
2005).  333 
Rett syndrome is an ASD in which patients appear to develop normally up to 6 – 18 months of 334 
age but then head growth decelerates, leading to microcephaly by the second or third year of life. 335 
Other symptoms include loss of language, social withdrawal, lack of eye contact, lack of 336 
response to social cues and stereotypic hand movements (Chahrour and Zoghbi, 2007). Most 337 
cases of Rett Syndrome are caused by mutations in the MECP2 gene, which encodes Methyl-338 
CpG-binding protein 2, a nuclear protein that binds to methylated 5-hydroxymethylcytosine or 339 
CpG sites required for chromatin organization and transcriptional regulation (Hendrich and Bird, 340 
1998; Lewis et al., 1992; Mellen et al., 2012). MECP2 expression is most abundant in neurons 341 
with the expression level increasing postnatally as neurons mature (Shahbazian et al., 2002). 342 
MECP2 regulates expression of Brain-derived neurotrophic factor (BDNF) which is a critical 343 
synaptic maturation factor maturation (Chahrour et al., 2008; Jordan et al., 2007; Nuber et al., 344 
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2005; Tudor et al., 2002). MECP2 is important for the development and the maintenance of 345 
synapses. It is essential for the transcription of biosynthetic enzymes crucial for 346 
neurotransmitters in respective neurons such as tyrosine hydroxylase in catecholamine neurons, 347 
GAD in inhibitory neurons and neuropeptides important for neuronal physiology such as 348 
corticotropin-releasing hormone, BDNF and somatostatin (Chao et al., 2010; Samaco et al., 349 
2009). Rodent models lacking functional MeCP2 reproduce features of Rett syndrome patients 350 
(Chen et al., 2001; Patterson et al., 2016; Pelka et al., 2006; Wu et al., 2016). Mouse models also 351 
showed a decrease in synaptic density and reduced LTP and synaptic plasticity (Moretti et al., 352 
2006). Similarly, in vitro data from neurons derived from human iPSC of Rett syndrome patients 353 
revealed decreased spontaneous postsynaptic currents with fewer synapses (Marchetto et al., 354 
2010). 355 
The finding that MECP2 overexpression or underexpression leads to Rett syndrome-like 356 
phenotypes further complicates the role of MECP2 suggesting that gene dosage is an important 357 
factor in ASD. This also suggests that ASD might reflect a failure of homeostatic regulation of 358 
synaptic function which makes sense as optimal synaptic function only occurs within a narrow 359 
dynamic range. Too much or too little of a protein might tilt the balance out of this range, 360 
resulting in ASD. 361 
3. Organoids generated by current protocols are not mature enough for a thorough 362 
investigation of their electrical properties 363 
Neuronal activity has been found in human organoids older than 3 months. 364 
Immunocytochemistry shows co-localization of pre- and post-synaptic markers in cortical 365 
organoids suggesting the formation of synapses (Birey et al., 2017; Pasca et al., 2015; Velasco et 366 
al., 2019; Xiang et al., 2019). Action potentials have been recorded in 50-80% of neurons within 367 
organoids in response to depolarization (Birey et al., 2017; Pasca et al., 2015; Xiang et al., 2019) 368 
and spontaneous firing has also been observed in organoids, which is lost after incubation with 369 
neurotransmitter antagonists (Birey et al., 2017; Pasca et al., 2015; Trujillo et al., 2019; Xiang et 370 
al., 2019). Furthermore, deep layer neurons in fetal neocortex show complex dendrite 371 
morphology at GW26 (Zhong et al., 2018) and neurons derived from stem cells display similar 372 
morphology nine months after transplantation into mouse cortex (Espuny-Camacho et al., 2013). 373 
However, despite the presence of synapses and action potentials, there is as yet no robust 374 
evidence for functioning neural networks with anatomically correct circuitry. This could be 375 
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because organoids lack the dorsoventral, anteroposterior and other axes found in embryonic 376 
brains, so although normal neuronal types differentiate efficiently in organoids, they are unlikely 377 
to be arranged in the appropriate anatomical locations relative to their prospective synaptic 378 
partners. Further, axonogenesis and synaptogenesis don’t become prominent in human embryos 379 
until around 5-7 months (de Graaf-Peters and Hadders-Algra, 2006; Zhong et al., 2018), 380 
suggesting organoids are too immature. Some studies have characterized the electrophysiological 381 
properties of neurons in the human fetal cortex. One study using whole-cell patch clamping on 382 
slice culture of prefrontal cortex found no action potentials detected in neurons at GW23 and 383 
only detected APs at GW26 (Zhong et al., 2018), coinciding with the expression of axonogenesis 384 
genes during GW19-26. 385 
While most organoid studies use transcriptomics to characterize their organoids, the presence of 386 
a transcript does not always indicate presence of functional protein. Expression of NMDA 387 
receptor subunit mRNA was detected in young human fetal neurons but its protein was not 388 
detected until >23 weeks (Eugenin et al., 2011). Therefore, expression of proteins in organoid 389 
neurons is likely a better marker of neuronal maturity. 390 
Some electrophysiological properties, such as increased capacitance and sodium and potassium 391 
currents, mature over time in organoids, indicating neuronal maturation with age (Qian et al., 392 
2016). Analysis of 10 month old organoids using multi-electrode arrays (MEA) showed 393 
consistently increased firing rates, burst frequency and synchrony indicating maturing neural 394 
networks. Notably, comparison of timing of electrical activity of pre-term human EEGs with the 395 
MEA recordings from cortical organoids showed organoids over 6 months old had high 396 
developmental age correlation, suggesting that the organoids follow an intrinsic developmental 397 
timeline (Trujillo et al., 2019). In a separate study, higher firing frequency was observed in 398 
thalamic organoids when they were fused to cortical organoids, suggesting that interactions 399 
between the organoids led to neuronal maturation (Xiang et al., 2019). Generating regionalized 400 
organoids may be limiting their maturation as extrinsic signals such as guidance molecules from 401 
neighbouring regions may be required for full maturation. 402 
Human ESC-derived neurons transplanted into mouse brain integrated and matured over a period 403 
of several months, eventually generating action potentials similar to those seen in adult humans. 404 
Intrinsic properties improved over time; membrane potential hyperpolarization, increase in 405 
maximum sodium currents, increased firing rates, dendritic length and dendritic spine density. 406 
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Two-photon and calcium imaging experiments found an increase in calcium activity in human 407 
neurons during mouse visual stimulation indicating synaptic integration within the host cortex 408 
(Linaro et al., 2019).   409 
These experiments show that stem cell derived neurons can mature to produce functionally 410 
similar neurons to those seen in vivo (Linaro et al., 2019; Trujillo et al., 2019) and can 411 
functionally integrate with local circuitry (Linaro et al., 2019). However, the process of 412 
maturation takes several months (6-10 months) (Linaro et al., 2019; Nicholas et al., 2013; 413 
Trujillo et al., 2019) following their own intrinsic developmental timeline independent of in vitro 414 
differentiation protocol or culture conditions (Linaro et al., 2019).  Extrinsic signals can improve 415 
maturation (Xiang et al., 2019) indicating some culture conditions may be limiting cortical 416 
organoid maturation. 417 
Despite their lack of maturation, the electrophysiological properties of cerebral organoids have 418 
been shown to model some aspects of disease phenotypes. For example, organoids harbouring 419 
mutations implicated in Alzheimer’s disease (AD) displayed increased levels of neurotransmitter 420 
transporter proteins and increased AP firing rates. This hyperexcitability has also been seen in 421 
AD mouse models and human brains (Ghatak et al., 2019). Hyperexcitability was also seen in 422 
organoids modelling Angelman Syndrome (AS), a neurodevelopmental disorder partly 423 
characterized by seizures. When compared to wild type, AS-cortical organoids showed increased 424 
firing with neurons in some organoids showing synchronous firing (Sun et al., 2019). Changes in 425 
electrophysiological properties were also found in Timothy Syndrome cortical organoids which 426 
displayed abnormal calcium signalling (Birey et al., 2017) and idiopathic ASD-cerebral 427 
organoids which required a more hyperpolarized membrane potential to inactivate sodium 428 
channels (Mariani et al., 2015). 429 
Organoids could well provide a useful tool for studying synaptic function in ASD but this will 430 
require improvements in differentiation protocols to allow normal maturation of neurons. This 431 
suggests that cerebral organoids, in their current form, are most appropriate for the study of 432 
earlier neurodevelopmental processes such as neurogenesis and cortical lamination rather than 433 
later processes such as synaptogenesis and neural circuit formation. 434 
 435 
4. Challenges in using cerebral organoids to model ASDs 436 
4.1 Differences between organoids and in vivo development 437 
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While there are many similarities between organoids and their in vivo counterparts, 438 
understanding the key differences can lead to improvements in the model. One major source of 439 
differences arises from the use of SMAD inhibition to direct stem cells toward neural fate. The 440 
human brain consists of more than just neural cells; non-ectodermal cells such as microglia, 441 
endothelial, blood cells and immune cells make up around 23-27% of fetal cortex at ages 15-442 
37pcw (Fan et al., 2018; Nowakowski et al., 2017). Microglia make up ~20% of fetal cortex cells 443 
from scRNA-seq studies (Fan et al., 2018; Nowakowski et al., 2017), and may be involved in 444 
ASD pathogenesis by dysfunctional synaptic pruning (Koyama and Ikegaya, 2015). 445 
Neuroimmunology is a large and expanding field as such many labs are working on ways to 446 
incorporate an immune system within the organoid model (Ormel et al., 2018) reported that 447 
omitting SMAD inhibition gave rise to organoids containing all three germ layers, ultimately 448 
allowing microglia to develop within the organoid. Microglia can also become incorporated 449 
within organoids by co-culturing them with iPSC-derived microglia (Lin et al., 2018). 450 
A major difference from the in vivo situation is the lack of vascularization in organoids, 451 
commonly leading to a necrotic core at their centre. Most cells within day 44 cortical organoids 452 
were associated with glycolysis compared to just 2% in fetal cortex, suggesting that organoid 453 
cells are metabolically stressed (Amiri et al., 2008). This abnormal rate of glycolysis could mask 454 
effects caused by ASD-causing mutations as studies have shown elevated glycolysis as a 455 
candidate cause of ASD (Vallee and Vallee, 2018). Stress pathways were found to be 456 
upregulated in cortical organoids, irrespective of protocol, cell line or organoid age (Bhaduri et 457 
al., 2020). Furthermore, these high stress levels limit cell type specification of organoid cells 458 
(Bhadouri et al., 2020). Transcriptomic comparison between fetal tissues and organoids suggest 459 
that major differences are due to tissue culture environment and not due to differences in 460 
differentiation (Camp et al., 2015). To improve nutrient and oxygen diffusion, spinning 461 
bioreactors (Lancaster et al., 2013), shaking culture systems (Lancaster and Knoblich, 2014) and 462 
sliced organoids (Qian et al., 2020) have been used. Using an air-liquid interface culture 463 
improves organoid survival, morphology and axon outgrowth (Giandomenico et al., 2019). Lack 464 
of vascularisation could also be the cause of the most striking difference between organoids and 465 
their in vivo counterpart, their size, with organoids being considerably smaller, possibly 466 
suggesting that processes involved in cortical expansion (Box 2) are not well recapitulated in 467 
organoids. Recently, Qian et al., (2020) showed that sustained growth of organoids can be 468 
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maintained by slicing organoids open to improve diffusion. Progenitor zones of sliced organoids 469 
continued to expand over time and were packed with NPCs, IPCs and oRGs, which are key cell 470 
types involved in cortical expansion. Despite their higher proliferative capacity, organoids did 471 
not undergo gyrification, although this could be induced by embedding organoids in ECM (Qian 472 
et al., 2020). 473 
 474 
4.2 Sources of Variation 475 
One of the main challenges in using organoids is their variability. Different laboratories tend to 476 
have their own in-house protocol in the generation of organoids and protocols vary in their 477 
differentiation efficiency depending on which cell line is used (Bershteyn et al., 2017; Birey et 478 
al., 2017; Lancaster et al., 2013; Xiang et al., 2019). There are multiple sources of technical 479 
variation between organoid differentiation protocols, for example recombinant proteins used to 480 
promote differentiation, Matrigel, and serum all have some batch effects during their production. 481 
Ideally, it would be helpful to have a systematic analysis of all published protocols and an agreed 482 
standardized protocol to be used in organoid generation. Nonetheless, significant efforts have 483 
been made to tackle this issue. A recent study comparing individual organoids generated from 484 
different lines and different batches using single-cell RNA-seq analysis showed very low 485 
organoid-to-organoid variability when careful quality control checks such as checks for neural 486 
differentiation were used during the process of organoid differentiation (Velasco et al., 2019). 487 
A common issue when using PSCs in cell culture, particularly for prolonged culture or during 488 
stressful events such as gene editing, is their propensity to acquire genetic changes which may 489 
alter their growth, transcriptome and/or differentiation, ultimately confounding experimental 490 
results (Mills et al., 2013). PSCs appear to incur non-random genetic abnormalities, the most 491 
abundant being chromosomal duplications or deletions. These can be assayed by karyotyping or 492 
qPCR (Baker et al., 2016). More subtle mutations such as SNP or CNVs can also occur in PSCs 493 
with apparently normal karyotype thus SNP arrays and/or genome sequencing should be 494 
performed on all lines used during experiments (Mills et al., 2013). However, these techniques 495 
may miss some genetic alterations thus it is important to use multiple clonal lines for 496 
experiments. 497 
 498 
5. Future perspectives 499 
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Organoids provide a powerful, amenable in vitro system to study normal embryonic human brain 500 
development and how it is disrupted in neurodevelopmental disorders. Advances in imaging 501 
technologies and gene editing have opened multiple avenues to dissect the roles of specific genes 502 
during human brain development using organoids. Using advanced imaging of cortical 503 
organoids, such as light-sheet live-cell imaging microscopy (Held et al., 2018), will allow 504 
scientists to track in real-time the high dynamic processes of human neurogenesis.  505 
However, there are still many challenges facing the use of cortical organoids for studying ASD. 506 
One of the most obvious is the lack of any behavioural readout from organoids. Currently, ASD 507 
is diagnosed solely on behavioural characteristics but organoid studies might elucidate cellular 508 
phenotypes/readouts that were missed from studies using other model systems, given that human 509 
neurodevelopment is still relatively understudied and there are important interspecies differences 510 
(Rakic, 2009). Recent advances in sequencing technology and data analysis have increased our 511 
ability to understand complex neurodevelopmental disorders such as ASD by finding converging 512 
pathways (Pinto et al., 2014; Wen et al., 2016). Coupling that with organoid technology, one can 513 
imagine sequencing and bioinformatic analyses of ASD patient-derived cerebral organoids might 514 
provide new biomarkers for diagnosing ASD, instead of relying on behavioural phenotypes. 515 
Synaptogenesis and neural circuit formation are significant points of convergence in ASD-risk 516 
genes. Electrophysiological studies of cerebral organoids are limited in their current state due to 517 
the long maturation time needed for circuit formation. This is not helped by culture conditions 518 
which appear to induce stress on the organoids, limiting or even regressing neuronal maturity 519 
(Bhaduri et al., 2020). Despite these limitations some cellular phenotypes of neurodevelopmental 520 
disorders have been modelled using cerebral organoids (Table 1). Moreover, now that we have 521 
identified stress factors that limit neuronal progenitor maturation in organoids (Bhaduri et al., 522 
2020), we can proceed to improve organoid culture conditions, for example by redesigning cell 523 
culture media to better support neuronal maturation or the use of microfluidics to enhance 524 
nutrient intake. 525 
It is challenging to link genotype with behavioral phenotype in ASD as ASD linked mutations 526 
often show incomplete penetrance. For example, only 26% of individuals carrying the 16p11.2 527 
duplication are diagnosed with ASD, and around 37% of carriers of the duplication have no 528 
psychiatric diagnosis (Niarchou et al., 2019). Furthermore, monozygotic twins only show a 70% 529 
ASD concordance rate (Folstein and Rosen-Sheidley, 2001). Stochastic events and/or 530 
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environmental differences during early brain development may make one twin more susceptible 531 
to the effects of the mutation, leading to a more severe phenotype. While we might consider the 532 
current variability in organoids to be a confounding element in interpreting experimental results, 533 
this variability could hold the key in understanding the stochasticity and/or environmental 534 
differences that we find in monozygotic twins. More systematic studies will have to be 535 
undertaken to explore this, but the advent of organoids allows us for the first time to test this 536 
hypothesis. 537 
Although cerebral organoids contain most of the cell types found in the brain, some important 538 
cell types are absent, such as microglia, which normally originate outside the brain (Bhaduri et 539 
al., 2020; Tanaka et al., 2020). Therefore, it is still difficult to model cellular aspects of ASD 540 
pathologies such as neuroinflammation (which requires the presence of microglia) or white 541 
matter abnormalities. However, there are already efforts in increasing the complexity of the 542 
cerebral organoid culture system through the use of co-culture with other cell types such as 543 
microglia (can be used to model neuroinflammation) (Song et al., 2019) and co-culturing with 544 
different brain regions to study axon tracts (to study white matter abnormalities) (Birey et al., 545 
2017; Cullen et al., 2019; Xiang et al., 2019). 546 
Despite their current limitations, cerebral organoids provide us with a valuable additional tool to 547 
investigate the etiology of autism. As better high-throughput techniques such as scRNA-seq and 548 
osmFISH (Codeluppi et al., 2018) are developed, more information can be obtained from the 549 
limited human fetal and embryonic samples. This increased human data, coupled with cellular 550 
data from 2D and maturing human cerebral organoid and behavioural data from animal models, 551 















Box 1 566 
Embryonic development of the cerebral cortex: a primer 567 
The development of the cerebral cortex can be divided into several stages (see Figure). 1. 568 
Patterning: The basic plan of the mammalian brain is laid out at the neural plate stage. At this 569 
stage, signaling centres that surround the neural plate produce signaling molecules including 570 
FGFs, BMPs and SHH which form a set of intersecting gradients across the neuroectoderm. 571 
Combinations of these signals are believed to confer specific regional fate on neural plate cells 572 
(Hebert and Fishell, 2008). Next, in the process of neurulation (2), the edges of the neural plate 573 
fold towards each other and fuse together, thus forming the neural tube. At the earliest stages, the 574 
neural tube contains three primary brain vesicles, the prosencephalon (forebrain), mesencephalon 575 
(midbrain) and the rhombencephalon (hindbrain) (Ishikawa et al., 2012). The prosencephalon 576 
expands disproportionately, becoming larger than the other vesicles. Each vesicle subsequently 577 
gives rise to specific parts of the brain. For example, the prosencephalon will give rise to the 578 
cerebral cortex, ventral telencephalon, thalamus and hypothalamus (Wilson and Houart, 2004). 579 
In the early neural tube, neuroepithelial progenitor cells divide symmetrically at the ventricular 580 
edge, giving rise to two daughter progenitors. These proliferative divisions rapidly expand the 581 
pool of neural progenitors (Florio and Huttner, 2014; Rakic, 1974). Neuroepithelial progenitor 582 
cells subsequently transform to form other progenitor types, primarily radial glia. Radial glia 583 
may divide either symmetrically or asymmetrically, giving rise to a radial glial and a neuronal 584 
daughter, thus initiating the process of neurogenesis (3) in which cortical neurons are born. As 585 
development proceeds, an increasing proportion of radial glia divide asymmetrically, generating 586 
large numbers of neurons. Another important population of neural progenitors, known as 587 
intermediate progenitors or apical progenitors, are found in the subventricular zone (SVZ) 588 
(Florio and Huttner, 2014; Noctor et al., 2001; Noctor et al., 2004; Tan and Shi, 2013). 589 
Intermediate progenitors then continue to divide, making more neurons. Newborn neurons 590 
migrate (4) radially (indicated by black arrows) towards the outer (pial) edge of the embryonic 591 
cortex guided by a scaffold provided by radial glial fibers that project from the ventricular edge 592 
to the pial surface. Early-born neurons populate the deepest layers of the cortex. Later born 593 
neurons migrate past them, progressively building up the characteristic six-layered of the cortex, 594 
in the process of lamination (Rakic, 1974, 1988, 2009; Seto and Eiraku, 2019; Tan and Shi, 595 
2013). Neurons in each cortical layer have distinct molecular signatures, associated with their 596 
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specific functions. Excitatory (glutamatergic) cortical neurons are generated in dorsal 597 
telencephalon, but inhibitory (GABAergic) cortical neurons are born in the ventral 598 
telencephalon, form where they migrate tangentially into the forming cortex. Once cortical 599 
neurons have migrated to their final destinations, they next form connections with their 600 
appropriate synaptic partners in the process of synaptogenesis (5), the first step in neural circuit 601 
assembly. During synaptogenesis, cell adhesion molecules such as neuroligins and neurexins are 602 
recruited to the site of the future synapse where they form a bridge between the axon and 603 
dendrite. This initiates protein specialization to organize the active zone of the presynaptic 604 
terminal and the post synaptic density (PSD) over a period of hours to days (Okabe et al., 2001). 605 
During this process, scaffolding proteins such as membrane‐associated guanylate kinases 606 
(MAGUKs), PSD95, and SHANK1 are recruited to the site of axo-dendritic membrane contact 607 
(Butz et al., 1998; Irie et al., 1997). Next is the process of synapse stabilization (6). In rodents, 608 
thousands of synapses and dendritic spines per neuron are added in the period of 1 – 2 weeks of 609 
development but the majority of the synapses are removed or withdrawn and neuronal activity 610 
plays a key role in this (Gipson and Olive, 2017; Ozcan and Ozcan, 2018). Many of the proteins 611 
located in the developing PSD play a role in synapse stabilization as many were shown to 612 
regulate synapse number and size. Neuronal connections could be between neurons from other 613 
brain structures that are further away (long-ranged connectivity) or with neurons from the same 614 
region of the brain (local connectivity). These connections are not final as many connections are 615 
made throughout embryonic and early development of the brain which will then be refined later 616 
on in development as connections that are used more are strengthened (activity-based neural 617 
connections) while connections that are less used are pruned as describe in the process of 618 
synapse stabilization to establish mature neural circuits (Schuldiner and Yaron, 2015; Tierney 619 
and Nelson, 2009). Figure is modified, with permission, from Price et al., (2017).  620 
 621 
Box 2 622 
Cortical expansion in humans 623 
There are significant differences in the number, types and behaviour of cortical neural 624 
progenitors between mouse and human (see Figure). In mouse, early neuroepithelial cells (NEC, 625 
coloured red) divide symmetrically, to increase the size of the neuroepithelium before 626 
transforming to become radial glial progenitors (RGC, coloured blue). RGCs and apical 627 
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intermediate progenitor cells (aIPCs, coloured green) initially self-renew but gradually begin to 628 
undergo asymmetric divisions to produce either an intermediate progenitor cell (IPC, coloured 629 
orange) or a neuron (grey) (Farkas and Huttner, 2008). Most IPCs divide only once, producing 630 
two neurons. Once the balance of radial glial divisions shifts from self-renewal toward 631 
differentiative divisions, final neuronal output becomes restricted. Newborn neurons migrate 632 
radially through the intermediate zone (IZ) and subplate (SP) before settling in the cortical plate 633 
(CP). Equivalents of each of these progenitor types are found in primates, where they show 634 
increased self-renewal which, along with an increased starting population, leads to a larger VZ 635 
and SVZ (Smart et al., 2002; Zecevic et al., 2005). Primates, including human, have two 636 
proliferative subventricular layers, the inner and outer subventricular zones (iSVZ and oSVZ 637 
respectively). The oSVZ contains a variety of highly proliferative progenitor cells including 638 
outer radial glia (oRG, coloured yellow) which give rise to large numbers of cortical neurons 639 
(Fietz et al., 2010; Hansen et al., 2010). oRG are abundant in human embryonic cortex, but 640 
extremely rare in mouse. Further, neurogenesis takes place for longer in human cortex compared 641 
to mouse, allowing more rounds of cell division. Overall, the combination of higher starting cell 642 
population, additional progenitor types, higher proliferative capacity of progenitors and longer 643 
time-window for neurogenesis have contributed to the large expansion of human cortex 644 
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Figure Legend 1084 
Figure 1 Sections of (A) 30 day, (B) 45 day and (C) 65 day old cerebral organoid grown from 1085 
wild-type human iPSCs. (A) Immunostaining for progenitor marker PAX6 (red) and deep layer 1086 
neuronal marker CTIP2 (green). (B) Immunostaining for intermediate progenitor marker TBR2 1087 
(green), deep later neuronal marker TBR1 (red) and deep layer neuronal marker CTIP2 (white). 1088 
(C) Immunostaining for progenitor marker PAX6 (yellow), deep layer neuronal marker CTIP2 1089 
(red) and upper layer neuronal marker SATB2 (green). Progenitors are located interiorly, near 1090 
the central lumen whereas differentiated neurons are located towards the outer edge of the 1091 
organoid and multiple time-points show that neuronal layers are progressively established, 1092 
resembling in vivo embryonic cortex. L = lumen, O = outer edge. Scale bar: 100µm. 1093 
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